Found: 39
Select item for more details and to access through your institution.
Influences of quality of maternal care and environmental enrichment on associative memory function in rats with early life lead exposure.
- Published in:
- Brain & Behavior, 2024, v. 14, n. 9, p. 1, doi. 10.1002/brb3.70040
- By:
- Publication type:
- Article
Gangliosides: Treatment Avenues in Neurodegenerative Disease.
- Published in:
- Frontiers in Neurology, 2019, p. 1, doi. 10.3389/fneur.2019.00859
- By:
- Publication type:
- Article
Retinal Pathology detected by optical coherence tomography in an animal model of Parkinson's disease.
- Published in:
- Movement Disorders, 2014, v. 29, n. 12, p. 1547, doi. 10.1002/mds.25974
- By:
- Publication type:
- Article
The neurobiological basis of cognitive impairment in Parkinson's disease.
- Published in:
- Movement Disorders, 2014, v. 29, n. 5, p. 634, doi. 10.1002/mds.25857
- By:
- Publication type:
- Article
Levodopa improves motor deficits but can further disrupt cognition in a macaque parkinson model.
- Published in:
- Movement Disorders, 2013, v. 28, n. 5, p. 663, doi. 10.1002/mds.25258
- By:
- Publication type:
- Article
Lead neurotoxicity in children: basic mechanisms and clinical correlates.
- Published in:
- Brain: A Journal of Neurology, 2003, v. 126, n. 1, p. 5, doi. 10.1093/brain/awg014
- By:
- Publication type:
- Article
Alterations in dopamine uptake sites and D1 and D2 receptors in cats symptomatic for and recovered from experimental parkinsonism.
- Published in:
- Synapse, 1995, v. 19, n. 1, p. 46, doi. 10.1002/syn.890190107
- By:
- Publication type:
- Article
Effects of the alpha-2 adrenoceptor agonist guanfacine on attention and working memory in aged non-human primates.
- Published in:
- European Journal of Neuroscience, 2011, v. 34, n. 6, p. 1018, doi. 10.1111/j.1460-9568.2011.07815.x
- By:
- Publication type:
- Article
Different Behavioral Experiences Produce Distinctive Parallel Changes in, and Correlate With, Frontal Cortex and Hippocampal Global Post-translational Histone Levels.
- Published in:
- Frontiers in Integrative Neuroscience, 2018, p. 1, doi. 10.3389/fnint.2018.00029
- By:
- Publication type:
- Article
Altered expression of glycobiology-related genes in Parkinson's disease brain.
- Published in:
- Frontiers in Molecular Neuroscience, 2022, v. 15, p. 1, doi. 10.3389/fnmol.2022.1078854
- By:
- Publication type:
- Article
PET imaging of dopamine release in the frontal cortex of manganese‐exposed non‐human primates.
- Published in:
- Journal of Neurochemistry, 2019, v. 150, n. 2, p. 188, doi. 10.1111/jnc.14681
- By:
- Publication type:
- Article
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson's Disease.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-42847-x
- By:
- Publication type:
- Article
Autism and Autistic Symptoms Associated with Childhood Lead Poisoning.
- Published in:
- Journal of Applied Research, 2005, v. 5, n. 1, p. 80
- By:
- Publication type:
- Article
Developmental Lead Exposure and Prenatal Stress Result in Sex-Specific Reprograming of Adult Stress Physiology and Epigenetic Profiles in Brain.
- Published in:
- Toxicological Sciences, 2018, v. 163, n. 2, p. 478, doi. 10.1093/toxsci/kfy046
- By:
- Publication type:
- Article
Genetic Diversity Influences the Response of the Brain to Developmental Lead Exposure.
- Published in:
- Toxicological Sciences, 2014, v. 141, n. 1, p. 29, doi. 10.1093/toxsci/kfu101
- By:
- Publication type:
- Article
Effects of Developmental Lead Exposure on the Hippocampal Transcriptome: Influences of Sex, Developmental Period, and Lead Exposure Level.
- Published in:
- Toxicological Sciences, 2012, v. 129, n. 1, p. 108, doi. 10.1093/toxsci/kfs189
- By:
- Publication type:
- Article
Effects of Chronic Manganese Exposure on Glutamatergic and GABAergic Neurotransmitter Markers in the Nonhuman Primate Brain.
- Published in:
- Toxicological Sciences, 2009, v. 111, n. 1, p. 131, doi. 10.1093/toxsci/kfp124
- By:
- Publication type:
- Article
Evidence for Cortical Dysfunction and Widespread Manganese Accumulation in the Nonhuman Primate Brain following Chronic Manganese Exposure: A 1H-MRS and MRI Study.
- Published in:
- Toxicological Sciences, 2006, v. 94, n. 2, p. 351, doi. 10.1093/toxsci/kfl106
- By:
- Publication type:
- Article
Relationship between Motor Symptoms, Cognition, and Demographic Characteristics in Treated Mild/Moderate Parkinson’s Disease.
- Published in:
- PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0123231
- By:
- Publication type:
- Article
No Sex Differences in Use of Dopaminergic Medication in Early Parkinson Disease in the US and Canada - Baseline Findings of a Multicenter Trial.
- Published in:
- PLoS ONE, 2014, v. 9, n. 12, p. 1, doi. 10.1371/journal.pone.0112287
- By:
- Publication type:
- Article
Effects of the novel histamine H3 receptor antagonist S 38093 in a non-human primate model of cognitive dysfunction
- Published in:
- 2009
- By:
- Publication type:
- Abstract
Neuroprotection in Parkinson models varies with toxin administration protocol.
- Published in:
- European Journal of Neuroscience, 2006, v. 24, n. 11, p. 3174, doi. 10.1111/j.1460-9568.2006.05192.x
- By:
- Publication type:
- Article
[<sup>125</sup>I]Iodomethyllycaconitine binds to α7 nicotinic acetylcholine receptors in monkey brain.
- Published in:
- European Journal of Neuroscience, 2006, v. 23, n. 10, p. 2604, doi. 10.1111/j.1460-9568.2006.04804.x
- By:
- Publication type:
- Article
Chronic Low-Dose MPTP in Nonhuman Primates: A Possible Model for Attention Deficit Disorder.
- Published in:
- Journal of Child Neurology, 1991, v. 6, p. S82, doi. 10.1177/088307389100600110
- By:
- Publication type:
- Article
Anatomical evidence of the projection of pontine omnipause neurons to midbrain regions controlling vertical eye movements.
- Published in:
- Journal of Comparative Neurology, 1989, v. 289, n. 4, p. 610, doi. 10.1002/cne.902890407
- By:
- Publication type:
- Article
The dopamine D<sub>3</sub> receptor antagonist, S33138, counters cognitive impairment in a range of rodent and primate procedures.
- Published in:
- International Journal of Neuropsychopharmacology, 2010, v. 13, n. 8, p. 1035, doi. 10.1017/S1461145710000775
- By:
- Publication type:
- Article
Altered expression of genes involved in ganglioside biosynthesis in substantia nigra neurons in Parkinson’s disease.
- Published in:
- PLoS ONE, 2018, v. 13, n. 6, p. 1, doi. 10.1371/journal.pone.0199189
- By:
- Publication type:
- Article
Impairment of nigrostriatal dopamine neurotransmission by manganese is mediated by pre-synaptic mechanism(s): implications to manganese-induced parkinsonism.
- Published in:
- Journal of Neurochemistry, 2008, v. 107, n. 5, p. 1236, doi. 10.1111/j.1471-4159.2008.05695.x
- By:
- Publication type:
- Article
Increased APLP1 expression and neurodegeneration in the frontal cortex of manganese-exposed non-human primates.
- Published in:
- Journal of Neurochemistry, 2008, v. 105, n. 5, p. 1948, doi. 10.1111/j.1471-4159.2008.05295.x
- By:
- Publication type:
- Article
Repeatable battery for assessment of neuropsychological status in early Parkinson's disease.
- Published in:
- Movement Disorders, 2009, v. 24, n. 10, p. 1453, doi. 10.1002/mds.22552
- By:
- Publication type:
- Article
Experimental parkinsonism is associated with increased pallidal GAD gene expression and is reversed by site-directed antisense gene therapy.
- Published in:
- Movement Disorders, 2003, v. 18, n. 1, p. 32, doi. 10.1002/mds.10316
- By:
- Publication type:
- Article
Effects of SIB-1508Y, a novel neuronal nicotinic acetylcholine receptor agonist, on motor behavior in parkinsonian monkeys.
- Published in:
- Movement Disorders, 1998, v. 13, n. 4, p. 637, doi. 10.1002/mds.870130405
- By:
- Publication type:
- Article
The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.
- Published in:
- Movement Disorders, 1997, v. 12, n. 2, p. 148, doi. 10.1002/mds.870120204
- By:
- Publication type:
- Article
Intraventricular Sialidase Administration Enhances GM1 Ganglioside Expression and Is Partially Neuroprotective in a Mouse Model of Parkinson’s Disease.
- Published in:
- PLoS ONE, 2015, v. 10, n. 12, p. 1, doi. 10.1371/journal.pone.0143351
- By:
- Publication type:
- Article
Response to "Comment on 'Neurotoxicity and Outcomes from Developmental Lead Exposure: Persistent or Permanent?'".
- Published in:
- Environmental Health Perspectives, 2024, v. 132, n. 4, p. 048002-1, doi. 10.1289/EHP14978
- By:
- Publication type:
- Article
Neurotoxicity and Outcomes from Developmental Lead Exposure: Persistent or Permanent?
- Published in:
- Environmental Health Perspectives, 2023, v. 131, n. 8, p. 085002-1, doi. 10.1289/EHP12371
- By:
- Publication type:
- Article
Deficits in orofacial sensorimotor function in Parkinson's disease.
- Published in:
- Annals of Neurology, 1986, v. 19, n. 3, p. 275, doi. 10.1002/ana.410190309
- By:
- Publication type:
- Article
Binding of [<sup>99m</sup>Tc] TRODAT-1 to Dopamine Transporters in Patients with Parkinson's Disease and in Healthy Volunteers.
- Published in:
- Journal of Nuclear Medicine, 2000, v. 41, n. 4, p. 584
- By:
- Publication type:
- Article
GM1 Ganglioside as a Disease-Modifying Therapeutic for Parkinson's Disease: A Multi-Functional Glycosphingolipid That Targets Multiple Parkinson's Disease-Relevant Pathogenic Mechanisms.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 11, p. 9183, doi. 10.3390/ijms24119183
- By:
- Publication type:
- Article